Ann Surg Oncol25 Aug 2026
Salvage surgery for esophageal squamous cell carcinoma after proton beam chemoradiotherapy shows significant morbidity but no operative mortality, indicating careful patient selection is crucial.
Ann Surg Oncol20 Aug 2026
A recent study shows extensive lymph node metastases in esophageal carcinoma despite multimodality therapy, highlighting implications for surgical strategy.
Ann Surg18 Aug 2026
In 2,388 patients undergoing fundoplication or magnetic sphincter augmentation for reflux disease, body mass index of 35 or higher did not worsen symptom relief, medication independence, or five-year durability.
Ann Surg14 Aug 2026
A new competency assessment tool for magnetic sphincter augmentation enhances surgical quality assurance in esophageal procedures.
Gastrointest Endosc14 Aug 2026
Full-thickness myotomy (FTM) offers clinical outcomes similar to circular muscle myotomy (CMM) for achalasia, but carries additional safety risks.
Gastrointest Endosc13 Aug 2026
EUS-guided gastroenterostomy (EUS-GE) shows superior outcomes for malignant gastric outlet obstruction (MGO) compared to traditional surgical approaches.
JAMA Surg13 Aug 2026
Molecular profiling of gastric cancer tumors can improve risk stratification for recurrence post-surgery.
Ann Surg11 Aug 2026
A multicenter study shows that removing at least 25 lymph nodes during surgery for esophageal adenocarcinoma post-chemotherapy leads to better outcomes.
Ann Surg Oncol11 Aug 2026
Robotic gastrectomy significantly lowers severe complications and boosts treatment outcomes in patients with advanced gastric cancer.
Ann Surg Oncol11 Aug 2026
A novel 8-point G-CMAP score can help surgeons predict postoperative complications after gastrectomy for gastric cancer, enhancing patient selection.